Nukkleus (NASDAQ:NUKK) Insider Anastasiia Kotaieva Sells 30,000 Shares

January 1, 2026 by InsiderTrades.com

Key Points

Insider selling: Director Anastasiia Kotaieva executed multiple block trades between Dec. 18–29, selling roughly 394,952 shares at about $4–$4.72 per share for approximately $1.75M in proceeds, a move that could create short‑term selling pressure.
Tiltan acquisition: Nukkleus completed the purchase of Israeli defense‑software firm Tiltan, adding ~30 years of defense AI expertise and relationships with IAI, Elbit and Rafael, though purchase price and expected financial impact haven’t been disclosed.
Stock profile & sentiment: Nukkleus has a small market cap (~$67.1M), a 12‑month range of $3.31–$40.98, 50/200‑day moving averages of $5.61/$6.77, and an average analyst rating of Sell (with mixed recent notes from Weiss Ratings and Wall Street Zen).

Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) insider Anastasiia Kotaieva sold 30,000 shares of the company's stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $4.41, for a total value of $132,300.00. Following the transaction, the insider owned 1,331,197 shares of the company's stock, valued at approximately $5,870,578.77. This represents a 2.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Anastasiia Kotaieva also recently made the following trade(s):

On Monday, December 29th, Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock. The stock was sold at an average price of $4.09, for a total value of $306,750.00.
On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The shares were sold at an average price of $4.26, for a total value of $236,873.04.
On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.57, for a total value of $319,900.00.
On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total value of $317,100.00.
On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The stock was sold at an average price of $4.72, for a total transaction of $182,871.68.

Nukkleus Stock Performance

Shares of NASDAQ NUKK opened at $4.03 on Thursday. The firm's 50-day moving average price is $5.61 and its 200-day moving average price is $6.77. The stock has a market capitalization of $67.10 million, a price-to-earnings ratio of 0.25 and a beta of -6.75. Nukkleus Inc. has a 12-month low of $3.31 and a 12-month high of $40.98.

Wall Street Analyst Weigh In

NUKK has been the subject of a number of recent research reports. Weiss Ratings reissued a "sell (d+)" rating on shares of Nukkleus in a research note on Wednesday, December 24th. Wall Street Zen raised Nukkleus from a "sell" rating to a "hold" rating in a research report on Sunday, November 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Nukkleus presently has an average rating of "Sell".

View Our Latest Report on NUKK

Institutional Investors Weigh In On Nukkleus

A number of hedge funds have recently added to or reduced their stakes in NUKK. UBS Group AG boosted its holdings in Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company's stock valued at $564,000 after purchasing an additional 15,223 shares during the period. Ausdal Financial Partners Inc. acquired a new position in Nukkleus during the 3rd quarter worth approximately $105,000. Finally, BNP Paribas Financial Markets purchased a new stake in Nukkleus during the 2nd quarter worth about $56,000. 12.47% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Nukkleus

Here are the key news stories impacting Nukkleus this week:

Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established relationships with IAI, Elbit and Rafael — this expands Nukkleus’s product set and potential defense-market revenue opportunities. Nukkleus Completes Tiltan Acquisition
Neutral Sentiment: Multiple outlets circulated the acquisition announcement (TipRanks, MSN), increasing visibility but not yet providing financial details (purchase price, expected revenue or integration plan), so near-term impact on earnings is uncertain. TipRanks Announcement
Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold a series of block trades between Dec. 22–29 totaling ~286,208 shares for roughly $1.25M in proceeds (sales at ~$4.09–$4.57). Large, concentrated insider sales can create short-term selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.